ACOR - ACORDA THERAPEUTICS INC
This page shows which of the focused investors we track hold ACOR and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2019 it was held by 1 manager with an aggregate reported value of $6.09M, which is 0.00% of the combined portfolio.
As of Q2 2019, 1 tracked institutional manager held ACOR (ACORDA THERAPEUTICS INC) with an aggregate reported value of $6.09M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ACOR — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2019
- Ticker
- ACOR
13F data is delayed and excludes shorts/non-13F assets.
Holders
Other instruments
Bonds, warrants, or other non-share-class principal positions in ACOR.
| 1 | Howard Marks - Oaktree Capital Management | Reduce -57.2% | 7,114,000 | $6.09M |
Loading holder history for ACOR…